Die proliferative Vitreoretinopathie

Zusammenfassung

Die proliferative vitreoretinale Retinopathie (PVR) ist die schwerste Komplikation der vitreoretinalen Chirurgie. Die PVR ist durch eine komplexe zelluläre Reaktion charakterisiert, die einer vitreoretinalen Wundheilungsreaktion entspricht und zu traktiven und durch Membranen fixierten Netzhautablösungen führt. Die Entfernung von aktiven Zellen und Membranen und insbesondere die komplette Glaskörperentfernung ist ein rationales Behandlungsziel, das nur chirurgisch erreicht werden kann.

Abstract

Proliferative vitreoretinal retinopathy (PVR) is a very severe complication of vitreoretinal surgery. PVR is characterised by a complex cellular reaction. This corresponds to a vitreoretinal wound healing reaction and leads to tractional retinal detachment fixed by membranes. A rational goal of treatment is the removal of active cells and membranes, particularly the whole vitreous body; this can only be achieved surgically.

Schlüsselwörter

proliferative Vitreoretinopathie - Chirurgie - proliferative Netzhautablösung

Key words

vitreoretinopathy - surgery - retinal detachment

• Literatur

• 1 Charteris DG, Sethi CS, Lewis GP et al. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye (Lond) 2002; 16: 369-374
• 2 Kunavisarut P, Bijlsma WR, Pathanapitoon K et al. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Am J Ophthalmol 2010; 150: 218-222
• 3 Scott IU, Flynn jr. HW, Azen SP et al. Silicone oil in the repair of pediatric complex retinal detachments: a prospective, observational multicenter study. Ophthalmology 1999; 106: 1399-1407
• 4 Cibis PA. Vitreoretinal Pathology and Surgery in retinal Detachment. St. Louis: CV Mosby; 1989
• 5 Laqua H, Machemer R. Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 1975; 80: 602-618
• 6 [Anonymous] The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983; 90: 121-125
• 7 Heimann K, Wiedemann P Hrsg. Proliferative Vitreoretinopathie. Heidelberg: Kaden; 1989
• 8 Lean JS, Stern WH, Irvine AR et al. Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group. Ophthalmology 1989; 96: 765-771
• 9 Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002; 21: 127-144
• 10 Nagasaki H, Shinagawa K. Risk factors for proliferative vitreoretinopathy. Curr Opin Ophthalmol 1995; 6: 70-75
• 11 Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998; 17: 77-98
• 12 Iandiev I, Bringmann A, Wiedemann P. [Proliferative vitreoretinopathy–pathogenesis and therapy]. Klin Monatsbl Augenheilk 2010; 227: 168-174
• 13 Mietz H, Heimann K. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease. Br J Ophthalmol 1995; 79: 874-877
• 14 Hui YN, Hu D. Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease. Graefes Arch Clin Exp Ophthalmol 1999; 237: 601-605
• 15 Hiscott PS, Grierson I, McLeod D. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol 1985; 69: 810-823
• 16 Guidry C. The role of Müller cells in fibrocontractive retinal disorders. Prog Retin Eye Res 2005; 24: 75-86
• 17 Sramek SJ, Wallow IH, Stevens TS et al. Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmology 1989; 96: 835-841
• 18 McGillem GS, Dacheux RF. Rabbit retinal Müller cells undergo antigenic changes in response to experimentally induced proliferative vitreoretinopathy. Exp Eye Res 1999; 68: 617-627
• 19 Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 1992; 36: 373-384
• 20 Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 2011; 209: 139-151
• 21 Joussen AM, Lux A, Kirchhof B. Shifting of the proliferative vitreoretinopathy milieu after tamponade with heavy silicone oil in eyes prone to proliferative vitreoretinopathy and bleeding. Br J Ophthalmol 2009; 93: 128-129
• 22 Lu YB, Iandiev I, Hollborn M et al. Reactive glial cells: increased stiffness correlates with increased intermediate filament expression. FASEB J 2011; 25: 624-631
• 23 Hoerster R, Hermann MM, Rosentreter A et al. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment. Br J Ophthalmol 2013; 97: 450-453